Fennec Pharmaceuticals Stock (NASDAQ: FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) Stock

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Wall Street

CENX

DOGZ

FENC

MAZE

MBOT

MGOL

MYNA

ORIS

PLRX

PNBK

PSIG

REPL

SATL

SLDB

SMTC

STBX

YOSH

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

alibaba_logo

News

Intraday Update

Markets

Movers

AGYS

AKYA

AUGX

BABA

BETR

BIOL

BYND

CLOV

CTNT

DCTH

DWSN

EAST

FFIE

FOSL

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

INVO

JAMF

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MBIN

NOTV

NOVA

ONON

PLUG

PSFE

RENT

SCPX

SHIM

SMRT

Sony Group Corporation American Depositary Shares

SONY

SPCE

SPWR

STNE

SYRA

TLRY

UXIN

VUZI

WOOF

WULF

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Earnings

Penny Stocks

Eurozone

Commodities

Small Cap

Global

EHTH

EXTR

FWBI

GROM

LIFW

PGEN

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday.

Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell 1.87% to 11,122.61. The S&amp;P 500 also fell, dropping, 1.26% to 3,966.28.

US Stocks Open Lower; Dow Dips 250 Points

Fennec Pharmaceuticals Inc. - Common Stock

Fennec Pharmaceuticals Inc

Earnings Misses

NDSN

Nordson Q1 2025 Adj. EPS $2.06 Misses $2.09 Estimate, Sales $615.000M Miss $639.242M Estimate

Host Hotels &amp; Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HST#NASDAQ">HST</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.40 by 10 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.43 billion which beat the analyst consensus estimate of $1.37 billion by 4.30 percent. This is a 7.94 percent increase over sales of $1.32 billion the same period last year.

Earnings Beats

Host Hotels & Resorts Q4 2024 Adjusted FFO $0.44 Beats $0.40 Estimate, Sales $1.43B Beat $1.37B Estimate

Ansys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANSS#NASDAQ">ANSS</a>) reported quarterly earnings of $4.44 per share which beat the analyst consensus estimate of $3.93 by 12.98 percent. This is a 12.69 percent increase over earnings of $3.94 per share from the same period last year. The company reported quarterly sales of $882.17 million which beat the analyst consensus estimate of $863.49 million by 2.16 percent. This is a 9.57 percent increase over sales of $805.11 million the same period last year.

ANSS

Ansys Q4 Adj $4.44 Beats $3.93 Estimate, Sales $882.17M Beat $863.49M Estimate

Trupanion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. This is a 180 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $337.31 million which beat the analyst consensus estimate of $335.41 million by 0.57 percent. This is a 14.01 percent increase over sales of $295.86 million the same period last year.

TRUP

Trupanion Q4 EPS $0.04 Misses $0.07 Estimate, Sales $337.31M Beat $335.41M Estimate

Tenaris Q4 2024 EPADS $0.94, Sales $2.845B Beat $2.712B Estimate

Grand Canyon Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) reported quarterly earnings of $2.95 per share which beat the analyst consensus estimate of $2.94 by 0.34 percent. This is a 6.5 percent increase over earnings of $2.77 per share from the same period last year. The company reported quarterly sales of $292.57 million which beat the analyst consensus estimate of $289.60 million by 1.03 percent. This is a 5.13 percent increase over sales of $278.28 million the same period last year.

LOPE

Grand Canyon Education Q4 Adj $2.95 Beats $2.94 Estimate, Sales $292.57M Beat $289.60M Estimate

During his most recent presidential campaign, <a href="https://www.benzinga.com/news/25/02/43628767/trump-freezes-billions-in-federal-funding-jobs-and-projects-in-clean-energy-conservation-and-transportation-left-in-limbo">Donald Trump</a> proposed eliminating taxes on Social Security benefits, a plan that found strong support among retirees who would like to keep more of their monthly checks. While tax cuts may sound like a good idea in the short term, finance experts have raised concerns about the long-term effects of such a policy.&nbsp;
"He's talking about getting rid of the taxation, which increases the benefits, but the very benefits that are subject to taxation will be much reduced," Nancy Altman, president for Social Security Works told <a href="https://www.kiplinger.com/taxes/whats-wrong-with-trumps-pledge-to-repeal-taxes-on-social-security-benefits">Kiplinger</a>. "So basically, it's not an honest proposal."
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li><a href="https://www.benzinga.com/money/arrived-centennial">Jeff Bezos-Backed Arrived Homes Hits A Big Sale On Charlotte Property – Investors Earning A 34.7% Return</a></li>
</ul>
The numbers suggest that <a href="https://www.benzinga.com/personal-finance/25/01/43276105/trumps-tax-plan-could-slash-social-security-benefits-33-by-2035-ramsey-show-host-george-kamel-weighs-in">cutting these taxes</a> could also speed up the depletion of the Social Security Trust Fund, offering immediate relief to some retirees now but ultimately creating significant challenges for future generations.
The <a href="https://budgetmodel.wharton.upenn.edu/issues/2025/2/10/eliminating-income-taxes-on-social-security-benefits">Penn Wharton Budget Model</a> estimates that removing taxes on Social Security benefits would result in a $1.5 trillion revenue loss over the next decade and increase the federal debt. This would put a larger strain on the Social Security Trust Fund, pushing up its projected depletion date from December 2034 to December 2032.
Currently, Social Security benefits are taxed for individuals earning more than $25,000 ($32,000 for joint filers). Depending on the beneficiary&#8217;s total income, up to 85% of their benefits can be taxed. These taxes are critical to keeping the program afloat.&nbsp;
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Higher-income retirees would stand to gain the most from the elimination of these taxes. Some of the wealthiest households could save over $100,000 throughout their lifetimes. Retirees in the middle-income range would also benefit, though to a lesser degree.
With more disposable income, some retirees may increase their spending, which could provide a short-term economic boost. But, higher spending among retirees does not necessarily translate into economic growth, especially if it's at the expense of national savings and investment.
While retirees would see immediate tax savings, younger generations might end up paying the price. The Penn Wharton Budget Model projects that eliminating Social Security taxes would add 7% to the federal deficit by 2054. This rising debt could cut into capital investment, leading to wage reductions of 0.4% over the next decade and 1.8% by 2054.
See Also: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
Young workers, particularly those under 30, would be most affected. A child born on the day the policy is enacted could face a $10,000 reduction in lifetime welfare benefits. As the trust fund nears insolvency, younger generations might face major cuts to their benefits in the future.
Eliminating these taxes could also have broader economic implications. If retirees have more after-tax income, they may feel less need to save for retirement. Over time, this could lead to lower national savings and a reduction in productive capital. The Penn Wharton Budget Model projects that, by 2054, GDP could be 2.1% lower under this policy than if the current system were kept in place.
On the surface, eliminating Social Security income taxes might seem like a win for retirees. But looking at the broader picture, the story changes. High-income retirees would benefit most, while younger workers and future generations may bear the brunt of the rising federal debt and possible benefit cuts. As lawmakers consider changes to <a href="https://www.benzinga.com/personal-finance/25/02/43580701/85-of-americans-willing-to-raise-taxes-to-save-social-security-survey-shows">Social Security</a>, they'll have to balance short-term relief with the long-term health of the program.
Read Next:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li><a href="https://www.benzinga.com/money/arrived-private-credit-fund">Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom</a></li>
</ul>

Personal Finance

Eliminating Social Security Income Taxes Would Cost $1.5 Trillion And Deplete The Trust Fund By 2032—Who Wins And Who Loses?

<img alt="Inflation of the of the US dollar — Photo" class="article-image-one" src="https://www.marketbeat.com/logos/articles/med_20250212140311_3-stocks-to-hedge-against-inflations-persistence.jpg" style="height:800px; width:1200px" />
Inflation is officially back&mdash;and it&#39;s at its fastest pace since September 2023. According to the latest <a href="https://www.bls.gov/news.release/cpi.nr0.htm">Consumer Price Index data</a>, consumer prices rose 0.5% from December, resulting in an annual inflation rate of 3% for the 12 months that ended in January. This news came as a relative shock to investors, who had hoped that the worst of inflation was finally over.&nbsp;
If you&#39;ve got a feeling that inflation is here to stay, you&#39;re not alone. These three stocks are primed to protect your portfolio against the long-term effects of high inflation.
<h2>Cool, Consistent Dividends Could Translate to Returns on COLD</h2>
There are some sectors investors turn to when inflation rises, with equity REIT <a href="https://www.marketbeat.com/compare-stocks/">stocks</a> being one of the top options. Historically, <a href="https://www.marketbeat.com/types-of-stock/real-estate-investment-trusts-reits/">equity REITs</a> have outperformed inflation <a href="https://www.hartfordfunds.com/insights/market-perspectives/equity/which-equity-sectors-can-combat-higher-inflation.html">66% of the time and posted an average real return of 4.7%</a>. REITs are also one of the only types of company classifications required to pay out dividends to investors, adding to their value as an <a href="https://www.marketbeat.com/stock-ideas/top-3-etfs-to-hedge-against-inflation-in-2025/">inflation hedge</a>.
<a href="https://www.marketbeat.com/stocks/NYSE/COLD/">Americold Realty Trust (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/cold#NYSE">COLD</a>) boasts a 12-month price target of $29.17, representing a 35.22% potential upside. It offers a <a href="https://www.marketbeat.com/stocks/NYSE/COLD/dividend/">4.08% dividend yield</a> with a 34.27% annualized three-year dividend growth. When combined with its nationwide equity holdings, COLD is competitively positioned in the REIT market. &nbsp;
Experts&#39; estimated return values could be attributed to a series of both inflationary and consumer concerns. Offering a series of climate-controlled industrial storage services, COLD&#39;s essential safety services and status as an equity REIT prime it for returns during periods of high inflation.
This may be especially true in light of&nbsp;<a href="https://www.cdc.gov/bird-flu/situation-summary/index.html">recent H5 bird flu concerns</a>, with climate-controlled meat storage essential to reducing pathogen spread.&nbsp;
<h2>High-Tech Energy Gives First Solar an Edge</h2>
According to historical data, energy stocks are another inflation superstar, which outperform inflation 74% of the time and delivered an annual real return of 12.9% annually. <a href="https://www.marketbeat.com/stocks/NASDAQ/FSLR/">First Solar, Inc.&nbsp; (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/fslr#NASDAQ">FSLR</a>) is one of the most highly rated solar energy stocks, with a 3.04 Buy rating from experts&mdash;16% higher than the oil and energy sector as a whole.&nbsp;
Expert price estimates indicate that First Solar may be significantly undervalued. Shares are currently trading at close to a 52-week low, while the company&#39;s P/E ratio remains competitive at 13.71. Short interest is also healthy, with an acceptable short interest ratio of 2.4, though it has recently decreased by 19.44%, indicating a major recent improvement in shareholder sentiment.&nbsp;
First Solar currently holds a consensus price target of $276.38, representing a potential upside of <a href="https://www.marketbeat.com/stocks/NASDAQ/FSLR/forecast/">more than 72%</a> of its current price of about $160 per share. Improved sales outlook for 2026 and beyond is likely a major contributor to this high ranking, with a projected earnings growth rate of 56%.
While First Solar doesn&#39;t offer the same dividend potential as other picks on our list, it may offset this by offering&nbsp;<a href="https://www.marketbeat.com/learn/how-growth-investors-find-high-growth-stocks-and-maximize-returns/">growth stock potential</a> through its solar R&amp;D department.&nbsp;
<h2>ConocoPhillips Boasts Buy Ratings, Traditional Energy Protections</h2>
For investors who prefer a more traditional inflation hedge, upstream energy provider <a href="https://www.marketbeat.com/stocks/NYSE/COP/">ConocoPhillips (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/cop#NYSE">COP</a>) could be a value stock pick with dividend potential. With a 3.16% dividend yield and a 12.92% annualized <a href="https://www.marketbeat.com/stocks/NYSE/COP/dividend/">three-year dividend growth</a>, ConocoPhillips is poised to continue offering consistent, reliable dividend growth with a payout ratio of 40.05%.
As inflation concerns return, now could be the right time for savvy investors to increase holdings in ConocoPhillips. The stock is currently at close to a 52-week low average closing price of about $99 per share with a&nbsp;<a href="https://www.marketbeat.com/stocks/NYSE/COP/forecast/">consensus price target of $133.56</a>.
This represents a 35.5% potential upside, further supported by a general Buy rating from experts.&nbsp;
Recent financial reports are also solid. In its February 6th earnings report, ConocoPhillips beat consensus EPS estimates by more than 11%.
The company&#39;s earnings are expected to grow by an additional 7.71% next year, as well, putting current inventors in a solid position.&nbsp;
<h2><a href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&amp;RegistrationCode=SyndicatedArticleLink" style="text-decoration:none;color:var(--dark-blue); font-weight:500;">Where Should You Invest $1,000 Right Now?</a></h2>
Before you make your next trade, you&#39;ll want to hear this.
MarketBeat keeps track of Wall Street&#39;s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the <a href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&amp;RegistrationCode=SyndicatedArticleLink">five stocks</a> that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
<a class="btn btn-featured" href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&amp;RegistrationCode=SyndicatedArticleLink" style="text-decoration:none">See The Five Stocks Here </a>
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/3-stocks-to-hedge-against-inflations-persistence/">3 Stocks to Hedge Against Inflation&#39;s Persistence</a>&quot; first appeared on MarketBeat.

Equities

COLD

FSLR

3 Stocks To Hedge Against Inflation's Persistence

Mueller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) has outperformed the market over the past 20 years by 3.94% on an annualized basis producing an average annual return of 12.41%. Currently, Mueller Industries has a market capitalization of $9.28 billion. 
Buying $100 In MLI: If an investor had bought $100 of MLI stock 20 years ago, it would be worth $1,028.48 today based on a price of $81.61 for MLI at the time of writing.
<h3>Mueller Industries's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740000610_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Mueller Industries 20 Years Ago Would Be Worth This Much Today

Management

NRDS

NerdWallet Appoints Jun Hyung Lee As Chief Financial Officer, Effective March 17, 2025

Meaningfully derisks overall exposure to Russia-Ukraine aviation litigation
Provides preliminary catastrophe loss estimate for January 2025 California Wildfires
Fidelis Insurance Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIHL#NYSE">FIHL</a>) ("Fidelis Insurance Group" or the "Company"), a global specialty insurer, today announced an update to loss reserves in advance of reporting its fourth quarter and full year 2024 earnings. During the fourth quarter, the Company incurred net adverse prior year development attributable to its Aviation and Aerospace line of business of $287.2 million. This relates to business underwritten in the 2021 and 2022 underwriting years and impacted by the ongoing Russia-Ukraine aviation litigation.
In respect of the aviation litigation, the Company has been judiciously settling claims to derisk its overall exposure. In addition, the Company has strengthened reserves, in large part to make allowance for ongoing settlement discussions and also to reflect recent developments and new information received.
To date, the Company has successfully settled or is in various stages of settlement discussions in respect of approximately two-thirds of the total exposure related to lessor policy claims currently in litigation. Of the remaining lessor policy claims in litigation, a significant portion of these claims relate to the English trial that commenced in October 2024, in respect of which the Company continues to hold reserves based on a probabilistic model of potential court outcomes, incorporating recent developments and updated information received. The English trial concluded February 14, 2025, and a court judgment will be rendered in the coming months.
The prior year development has impacted the Company's fourth quarter and full-year performance. For the year ended December 31, 2024, the Company anticipates reporting net income in the range of $100 to $120 million and operating net income in the range of $120 to $140 million.
Dan Burrows, Group Chief Executive Officer, commented: "We have meaningfully reduced our overall exposure to the complex and evolving Russia-Ukraine aviation litigation, lowered the potential downside risk associated with this event and provided increased certainty to our shareholders.
Excluding the impact of the prior year development attributable to our Aviation and Aerospace line of business, our full-year results would have exceeded our long-term Operating ROAE target. Our balance sheet remains strong, and our business is well-positioned to support future growth and deliver long-term value for shareholders."
Separately, Fidelis Insurance Group announced today its preliminary estimate of catastrophe losses related to the January 2025 California wildfires. Based on an insured industry loss estimate of $40 billion to $50 billion, the Company expects its catastrophe loss estimates to be in the range of $160 million to $190 million, net of expected recoveries, reinstatement premiums and tax. The losses from these wildfires will be reflected in our first quarter 2025 earnings.

Guidance

FIHL

Fidelis Insurance Group Provides Update In Advance of Q4 Earnings;  Aviation Line Sees $287.2M Adverse Development Amid Russia-Ukraine Litigation; Expects FY Net Income Of $100M-$120M; Announces $160-$190M Catastrophe Loss Estimate from January 2025 California Wildfires

Assuming the secureWISE transaction closes in the first quarter of 2025, and with purchase accounting adjustments, the company expect to achieve 2025 gross margin in line with corporate gross margin, target model 20% operating margin, and for EPS to be slightly accretive.

PDFS

PDF Solutions Now Expects To Achieve 2025 Revenue Growth Rate Of 21% - 23% YoY Vs Prior View Of ~15% Growth

WIIM

CWAN

Clearwater Analytics shares are trading higher after the company reported better-than-expected Q4 EPS and revenue and issued FY25 revenue guidance above expectations.

Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) .

VMEO

Vimeo expects  FY 2025 revenue to grow in the low single digits with growth accelerating through the year.

Genco Shipping &amp; Trading (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNK#NYSE">GNK</a>) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.36 by 19.44 percent. This is a 32.56 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $99.20 million which beat the analyst consensus estimate of $90.46 million by 9.66 percent. This is a 14.12 percent decrease over sales of $115.52 million the same period last year.

Genco Shipping & Trading Q4 Adj EPS $0.29 Misses $0.36 Estimate, Sales $99.20M Beat $90.46M Estimate

Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) sees Q1 sales of $100.000 million vs $102.93 million analyst estimate.

Vimeo Sees Q1 2025 Sales $100.000M vs $102.93M Est

The Company also announced today that its Board of Directors approved a stock repurchase program which authorizes the repurchase of up to $200&nbsp;million of the Company's common stock. Share repurchases under this program may be made from time to time on the open market, in privately negotiated transactions or through accelerated share repurchase programs in the discretion of, and at prices to be determined by, the Company. The program will be in effect until February 28, 2026.
 &nbsp;

Buybacks

Old National Bancorp Approves Stock Repurchase Program Of Up To $200M Of The Company's Common Stock

Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.03 by 66.67 percent. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $103.16 million which beat the analyst consensus estimate of $100.52 million by 2.63 percent. This is a 2.26 percent decrease over sales of $105.54 million the same period last year.

Vimeo Q4 EPS $0.01 Misses $0.03 Estimate, Sales $103.16M Beat $100.52M Estimate

Carvana Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) reported fourth-quarter financial results after the market close on Wednesday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/02/b43830073/carvana-announces-record-fourth-quarter-and-full-year-2024-results">from the quarter</a>.
Q4 Earnings: Carvana reported fourth-quarter revenue of $3.55 billion, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $3.31 billion. The used car retailer reported fourth-quarter earnings of 56 cents per share, beating analyst estimates of 21 cents per share, according to <a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue was up 46% year-over-year. Carvana sold 114,379 vehicles in the fourth quarter, up 50% year-over-year. Net income totaled $159 million and net income margin came in at 4.5% in the fourth quarter. 
&#8220;In 2024, Carvana became the most profitable public automotive retailer in U.S. history as measured by Adjusted EBITDA margin while also resuming industry-leading growth,&#8221; said Ernie Garcia, co-founder and CEO of Carvana.
&#8220;This unique combination is the product of more than&nbsp;$10 billion, 10 years, and tens of millions of hours of hard work invested to develop a truly differentiated business model that delivers both better customer experiences and better results. With just ~1%&nbsp;market share today and many opportunities to improve and expand our offering from here, we know this is just the beginning of our journey to change the way people buy and sell cars.&#8221;
See Also: <a href="https://www.benzinga.com/tech/25/02/43820197/apple-unveils-iphone-16e-with-a18-chip-ai-features-599-price-tag">Apple Unveils iPhone 16e With A18 Chip, AI Features, $599 Price Tag</a>
Outlook:&nbsp;Carvana said it expects a sequential increase in retail units sold and adjusted EBITDA in the first quarter. The company also said it expects &#8220;significant growth&#8221; in both retail units sold and adjusted EBITDA in full-year 2025.
Carvana executives will further discuss the quarter on a conference call with investors and analysts at 5:30 p.m. ET.
CVNA Price Action: <a href="https://www.benzinga.com/quote/CVNA" target="_blank" rel="noreferrer noopener">Carvana shares</a> were up nearly 40% year-to-date heading into the print. The stock was down 6.8% after hours, trading at $262.90 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

CVNA

Carvana Stock Hits The Brakes Following Q4 Earnings: Revenue Beat, EPS Beat, Upbeat Guidance — 'This Is Just The Beginning'

Teekay Tankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNK#NYSE">TNK</a>) reported quarterly earnings of $1.50 per share which beat the analyst consensus estimate of $1.49 by 0.67 percent. This is a 48.45 percent decrease over earnings of $2.91 per share from the same period last year. The company reported quarterly sales of $258.35 million which beat the analyst consensus estimate of $185.16 million by 39.53 percent. This is a 24.29 percent decrease over sales of $341.23 million the same period last year.

Teekay Tankers Q4 Adj EPS $1.50 Beats $1.49 Estimate, Sales $258.35M Beat $185.16M Estimate

Press Releases

Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

Financing

Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

Comments

Fennec Pharmaceuticals

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga